EU eyes COVID-19 vaccines at less than $40, shuns WHO-led alliance—sources | Inquirer News
Close  

EU eyes COVID-19 vaccines at less than $40, shuns WHO-led alliance—sources

/ 09:54 PM July 24, 2020
coronavirus vaccine

FILE PHOTO: A small bottle labeled with a “Vaccine” sticker is held near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic

BRUSSELS—The European Union is not interested in buying potential COVID-19 vaccines through an initiative co-led by the World Health Organization as it deems it slow and high-cost, two EU sources told Reuters, noting the bloc was in talks with drugmakers for shots cheaper than $40.

The position shows the EU has only partly embraced a global approach in the race for COVID-19 vaccines as, while it is a top supporter of initiatives for worldwide equitable access, it prefers prioritizing supplies for the EU population.

ADVERTISEMENT

It could also deal a blow to the WHO-led COVAX initiative to secure vaccines for all.

“Using COVAX would lead to higher prices and later supplies,” one of the two officials said.

FEATURED STORIES

The WHO and GAVI, a public-private partnership that co-leads the COVAX initiative, had no immediate comment.

A COVAX mechanism meant to buy vaccines in advance is targeting a $40 price for shots in wealthy countries, the official said, adding the EU could buy at cheaper prices with its own scheme for upfront purchases.

The bloc is currently in talks with several drugmakers to secure in advance their potential vaccines against the coronavirus, officials told Reuters last week.

These possible deals would be financed with about 2 billion euros ($2.3 billion) from an EU rainy-day fund known as Emergency Support Instrument (ESI), officials said.

The EU also wants to secure vaccines by the end of the year, should they be available. This timetable “is not feasible” for COVAX, one official said.

PARALLEL TRACKS

The European Commission, which is the bloc’s executive arm and which leads EU talks with drugmakers, has advised EU states to join COVAX if they wish, but not for buying vaccines, the official said.

A Commission spokesman declined to comment.

ADVERTISEMENT

An official said joining the two initiatives may not be legally feasible, as EU states have accepted an exclusivity clause when they backed the EU advance purchase scheme.

Some EU states have expressed interest in joining COVAX but have not yet signed up.

The EU has been a keen supporter of global initiatives to secure vaccines for all. It has promoted two global fund-raising campaigns that have so far raised nearly $19 billion, of which three quarters came from EU states and institutions, to help develop COVID-19 vaccines and ensure equitable access.

However, taken aback by U.S. moves to secure potential vaccines and drugs, the EU has recently taken a more assertive role in the global race.

If vaccines are ever successful they are unlikely to be available in large amounts for a while. Purchasing them for the EU population could thus temporarily deprive poorer countries of doses.

The official said however that the two tracks to buy vaccines remained complementary, but added, “budgets are limited.”

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus vaccine, COVID-19, European Union, Health, WHO, world, World Health Organization
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.